Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis.
Naruhiro KimuraToru SetsuYoshihisa AraoNorihiro SakaiYusuke WatanabeHiroyuki AbeHiroteru KamimuraAkira SakamakiTakeshi YokooKenya KamimuraAtsunori TsuchiyaAkihiko OsakiKentarou IgarashiNobuo WaguriMasahiko YanagiToru TakahashiSoichi SugitaniYuka KobayashiMasaaki TakamuraAkira YoshikawaToru IshikawaToshiaki YoshidaToshiaki WatanabeHitoshi BannaiTomoyuki KubotaKazuhiro FunakoshiHiroto WakabayashiSo KuritaNorio OgataMasashi WatanabeYuhsaku MitaShigeki MoriMotoya SugiyamaToru MiyajimaSumio TakahashiShuichi SatoKisei IshizukaHironobu OhtaYutaka AoyagiShuji TeraiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
The cumulative risk of new symptom development is roughly 30% 20 years after diagnosis and could be predicted by factors including serum albumin levels, serum D-Bil level, and Paris II criteria.
Keyphrases